Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw
Cardiff
CF15 7QZ
UK
Person cyswllt: Jane Boult
Ffôn: +44 2921501500
E-bost: jane.boult@wales.nhs.uk
NUTS: UK
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: http://nwssp.nhs.wales/ourservices/procurement-services/
Cyfeiriad proffil y prynwr: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.2) Caffael ar y cyd
Caiff y contract ei ddyfarnu gan gorff prynu canolog
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Support for the Pharmaceutical Needs Assessment 2026
II.1.2) Prif god CPV
85100000
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
The Public Health (Wales) Act 2017 places a statutory duty on Health Boards in Wales to prepare and publish an assessment of pharmaceutical service needs. The NHS (Pharmaceutical Services) (Wales) Regulations 2020 specify the minimum content requirements for a Pharmaceutical Needs Assessment (PNA) and outline the process that must be followed during its development. To support implementation, the Welsh Government has issued non-statutory guidance for Health Boards (HBs).
The primary aim of a PNA is to enhance the planning and delivery of pharmaceutical services by ensuring Health Boards thoroughly assess the needs of their populations and align services accordingly. PNAs help Health Boards identify:
Where additional contractor premises may be needed
Where more dispensing doctors are required
Whether current providers are sufficiently meeting pharmaceutical needs
Where existing contractors may need to offer additional services
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 45 000.00 GBP
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
85100000
II.2.3) Man cyflawni
Cod NUTS:
UKL22
Prif safle neu fan cyflawni:
Cardiff and Vale University Health Board
II.2.4) Disgrifiad o’r caffaeliad
The Public Health (Wales) Act 2017 places a statutory duty on Health Boards in Wales to prepare and publish an assessment of pharmaceutical service needs. The NHS (Pharmaceutical Services) (Wales) Regulations 2020 specify the minimum content requirements for a Pharmaceutical Needs Assessment (PNA) and outline the process that must be followed during its development. To support implementation, the Welsh Government has issued non-statutory guidance for Health Boards (HBs).
The primary aim of a PNA is to enhance the planning and delivery of pharmaceutical services by ensuring Health Boards thoroughly assess the needs of their populations and align services accordingly. PNAs help Health Boards identify:
Where additional contractor premises may be needed
Where more dispensing doctors are required
Whether current providers are sufficiently meeting pharmaceutical needs
Where existing contractors may need to offer additional services
Once published, the PNA is used by Cardiff & Vale University Health Board (CAVUHB) to evaluate applications from pharmacies and dispensing appliance contractors seeking to open new premises or relocate existing ones. It also informs decisions on outline consent and premises approval applications submitted by dispensing doctors.
II.2.5) Meini prawf dyfarnu
Price
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Dyfarnu contract heb gyhoeddi galwad am gystadleuaeth yng Nghyfnodolyn Swyddogol yr Undeb Ewropeaidd ymlaen llaw
Cyfiawnhau'r weithdrefn ddyfarnu a ddewiswyd:
Dim tendrau neu ddim tendrau/ceisiadau i gymryd rhan addas mewn ymateb i weithdrefn gyfyngedig
Esboniad
Direct Award via NHS SBS Framework – Consultancy and Advisory Services for Health (reference SBS10197, Lot 2: Integrated Care, Healthcare and Community Care)
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
Section V: Dyfarnu contract
Rhif Contract: CAV-DCO-(25-26)106
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
13/10/2025
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 1
Nifer y tendrau a ddaeth i law gan BBaChau: 1
Nifer y tendrau a dderbyniwyd gan dendrwyr o Aelod-wladwriaethau yr UE: 1
Nifer y tendrau a dderbyniwyd gan dendrwyr o Aelod-wladwriaethau nad ydynt yn aelodau o'r UE: 0
Nifer y tendrau a ddaeth i law drwy ddulliau electronig: 0
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
Primary Care Commissioning
Suite 1A, West One, 114 Wellington Street
Leeds
LS111BA
UK
Ffôn: +44 7887627470
NUTS: UK
BBaCh yw’r contractwr:
Ydy
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Cyfanswm gwerth y contract/lot: 45 000.00 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
(WA Ref:156854)
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Ffôn: +44 2079477501
VI.5) Dyddiad anfon yr hysbysiad hwn
13/10/2025